🦊/Investors

Asabys Partners

Venture capital

Madrid · Seed–Growth · 18 people tracked

Find your way into Asabys Partners

3,096 people in our graph share verified history with the Asabys Partners team — schools, employers, funds. One of them is your warm intro.

Tyler Wilsonunlockedknows Guillem Masferrer · together at Ey (overlapped)
×2knows the team · via The London School of Economics and Political Science (LSE)
×3knows the team · via Ey
×2knows the team · via Harvard University
×3knows the team · via KPMG
knows the team · via University of Michigan Law School
Fox Verdict
Sign up to see your fit

Investment thesis

Asabys focuses on pushing the boundaries of science and medicine to improve patients' lives, backing highly innovative and transformative technologies. The firm positions itself as a hands-on partner and collaborator to its portfolio companies. It integrates environmental, social, and governance considerations into its investment processes and aligns its practices with the United Nations Sustainable Development Goals. Asabys is financially backed by the EU under the EFSI established through the Investment Plan for Europe.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Growth
HQ
Madrid, ES
Leads rounds
Follows
Instruments
Equity
Founded
2018
Last 12 months
1 investment
Tracked investments
34

Team · 18 people

from the firm's website & curated
Antonio Limatola· Senior Associate
Beatriz Gandarias· Senior Associate
Laia Romero· Executive Assistant
Mònica Sabé· Executive Assistant - Office Manager
Pilar Almajano· Financial Controllerin

What they invest in

from 28 of 34 portfolio companies

Healthtech ×18Medical Devices ×15Biotech ×13Digital Health ×10AI & Machine Learning ×8Deep Tech ×7Developer Tools ×2SaaS ×2

HQs:Spain×10France×2United States×2Belgium×1Germany×1Israel×1

Investments · 34 tracked

founders shown can be your intro path

By year:2025 · 32024 · 22023 · 32022 · 12021 · 12020 · 62019 · 117 dated

Nuagenuagetx.comin✓ verified

Nuage Therapeutics develops drug discovery technologies for disordered proteins, focusing on precision treatments for aggressive cancers with limited therapeutic options.

AI & Machine LearningBiotechDeep TechBarcelona, ES

Mateusz Biesaga(Founder and Chief Technology Officer)inXavier Salvatella(Founder)in

Co-investorsSofinnova PartnersBStartup

Safehealsafeheal.comin𝕏Series C · Sep 2025 · $12M✓ verified

SafeHeal is a medical device manufacturer developing anastomosis protection devices for colorectal surgery.

BiotechDigital HealthHealthtechMedical DevicesFrance, FR

Chris Richardson(President & CEO)inKarl Blohm(VP, International)inScott DePierro(VP, US Operations)inMarcos Velez-Duran(VP, Regulatory Affairs and Quality)inBrent Metzler(CFO)Michael Augelli(VP, R&D, Manufacturing)in

Co-investorsSofinnova Partners

Splice Biosplice.bioin𝕏Sep 2020✓ verified

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.

BiotechDeep TechDigital HealthBarcelona, ES

Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)

Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalCriteria Bio VenturesNew Enterprise Associates (NEA)+3 more

Accureaccure.health

Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.

BiotechHealthtech

Laurent Nguyen(CEO)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in

Co-investorsAliath BioventuresKinled Holding

Agomab Therapeuticsagomab.cominJul 2022

Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.

BiotechHealthtechMedical DevicesAntwerp, BE

Tim Knotnerus(Chief Executive Officer)in

Co-investorsEQT Life SciencesAdBio partnersAndera PartnersCanaan PartnersPontifax Venture CapitalV-Bio Ventures+1 more

ALLOXallox.bioin𝕏

ALLOX develops an AI-enabled platform that uses high-throughput genomics and machine learning to discover biophysical parameters governing protein function for drug discovery.

AI & Machine LearningBiotechDeep TechBarcelona, ES

Júlia Domingo(Founder)in

Amelia Virtual Careameliavirtualcare.comin𝕏Jan 2024 · $6M

XRHealth provides telehealth therapy delivered at home using FDA-registered VR/AR headsets, mobile apps, wearables, and prescription digital therapeutics (such as Stanza), combined with licensed clinicians.

Digital HealthHealthtechMedical Devices

Co-investorsBStartupShip2B

Anaconda Biomedanaconda.bioin𝕏Series B · Dec 2019 · $22M

Anaconda Biomed develops next-generation endovascular access and protection devices.

BiotechHardwareHealthtechMedical DevicesBarcelona, ES

Trent Reutiman(CEO)inHendrik Lambert(Vice-President of Clinical & Regulatory Affairs)inDr. Iñaki GalveJordi Cardonain

BoardMaria Jose Alonso

Co-investorsYsios CapitalEuropean Investment BankInnogest Capital

Augustine Therapeuticsaugustinetx.comin

Augustine Therapeutics is a biotech company developing HDAC6-targeted therapies for peripheral neuropathies such as Charcot-Marie-Tooth disease and chemotherapy-induced peripheral neuropathy, as well as neurodegenerative disorders like ALS.

BiotechMedical Devices

Co-investorsAdBio partnersJeito CapitalNovo HoldingsPMVV-Bio VenturesNewton Biocapital

Deepulldeepull.cominSeries B · Mar 2023 · $18M

Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.

Medical Devices

Co-investorsColumbus Venture Partners

Fabrafabra.cominOct 2020 · $20M

Fabra offers a 3D design editor that lets designers work from product templates to test fits, colors, fabrics, and graphics, then generate tech packs to share with manufacturers.

Advanced ManufacturingConsumerDeveloper ToolsRetail TechSaaSOrmond Beach, US

Nick Manks(Co-founder)inGloria(Co-founder)Luke(Co-founder)

Co-investorsRLC VenturesFrumtak VenturesJanuary CapitalNovatorSide Stage Ventures

FOR INVESTORSvaluat.com

Valuat develops software tools and financial services to improve efficiency, transparency and accessibility in European private markets for asset managers, investors, startups and fund managers.

Enterprise SoftwareFintechSaaS

Co-investorsNazca Capital S.G.E.I.C,Swanlaab Venture Factory

Gradientdenervationgradientdenervation.comin

Gradient Denervation develops a catheter-based medical device that uses ultrasound energy to ablate nerves around the pulmonary artery for treating pulmonary hypertension patients.

Deep TechHealthtechMedical DevicesParis, FR

Dr Swami Gnanashanmugam(Founder)

Inbiomotioninbiomotion.com

InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients.

BiotechDigital HealthMedical Devices

BoardProf Rob E. Coleman(Chairman)

Co-investorsCriteria Bio VenturesYsios CapitalAlta Life Sciences

INBRAIN Neuroelectronicsinbrain-neuroelectronics.cominSeed · Jun 2020 · $1M

INBRAIN Neuroelectronics develops graphene-based brain-computer therapeutics that combine neural signal decoding with AI to enable precision, adaptive treatments for neurological disorders.

AI & Machine LearningDeep TechMedical DevicesBarcelona, ES

Carolina Aguilar(CEO & Co-Founder)inKostas Kostarelos(Chair of the Vision Board & Co-Founder)Antòn Guimerà(Co-founder)Jerome Crocco(COO)inJurriaan Bakker(CTO)inEduard Ros(Interim CFO)in

Co-investorsBStartupVsquared VenturesAliath Bioventuresimec.xpand

Koa Healthkoahealth.com

Koa Health develops a unified digital mental health platform that delivers evidence-based treatment programs and clinical interventions.

Digital HealthHealthtechMental Health

Oliver Harrison(Chief Executive Officer)

Co-investorsBeresford VenturesCREAS IMPACTO GLOBAL SGEICMundi VenturesWessel ManagementYaday

Medasensemedasense.comin𝕏Series C · Sep 2020 · $18M

Medasense develops a noninvasive sensor platform and AI technology for objective pain measurement, helping clinicians personalize pain management and avoid overmedication.

AI & Machine LearningDigital HealthHealthtechMedical DevicesRamat Gan, IL

Galit Zuckerman-Stark(Founder and CEO)

Co-investorsOTVOlive Tree Ventures

Mediktormediktor.comin

Mediktor is an AI-powered healthcare chatbot platform that enables patients to assess symptoms and receive preliminary guidance through natural language conversations.

AI & Machine LearningDigital HealthHealthtechBarcelona, ES

Oscar García-Esquirol(Co-founder / Medical Director)inCristian Pascual(Founder)inRoger Forcada(CTO)in

Co-investorsAlta Life Sciences

Mybinxhealthmybinxhealth.comin

binx health develops FDA-cleared, CLIA-waived point-of-care diagnostic testing for chlamydia and gonorrhea in male and female patients, delivering central-lab-quality results in about thirty minutes so patients can test, get diagnosed, and receive treatment in one visit.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsOrbiMed

Onaona.comin𝕏Jun 2020

Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.

AI & Machine LearningCloud ComputingDeveloper Tools

Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesAlta Life SciencesColumbus Venture Partners+4 more

Ona Therapeuticsona-therapeutics.comin𝕏

Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.

BiotechHealthtechMedical Devices

Co-investorsFund+KorysMérieux Equity PartnersYsios CapitalAlta Life SciencesBpifrance+2 more

Orikines’s Websiteorikine.bioinSeed · Jul 2023 · $6M

Orikine Bio develops engineered cytokines called Foldikines™ to reprogram immune responses for treating autoimmune and inflammatory diseases.

BiotechDeep TechHealthtechMedical DevicesBarcelona, ES

Ariadna Montero(Scientific Founder, Head of Innovation Management & Corp. Comm.)inAlejo Chorny(Co-founder & Former-CEO)inProf. Luis Serrano(Scientific Founder, Advisor)Dr. Javier Delgado(Scientific Founder, Advisor)Christian Pangratz(CEO & Board Director)in

BoardLarry Edwards(Chairman of the Board)

Co-investorsAdBio partners

Peptomycpeptomyc.comin𝕏

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials.

BiotechDeep TechHealthtechMedical DevicesBarcelona, ES

Dr. Marie-Eve Beaulieu(Co-founder)Laura Soucek(Co-founder & CSO (former CEO))in

Co-investorsAurora ScienceInvivo Capital PartnersAlta Life Sciences

Qidaqida.esin𝕏Nov 2025

Qida provides in-home care services for elderly and dependent people in Spain, matching families with professional caregivers on a flexible basis (from one hour a week to live-in 24/7 care) with ongoing supervision by psychologists or social workers.

Digital HealthHealthtechLongevitySabadell, ES

Oriol Fuertes Cabassa(Founder)in

Co-investorsBStartupCREAS IMPACTO GLOBAL SGEICKibo VenturesMundi VenturesShip2BEndeavor Catalyst+2 more

Quibimquibim.comin𝕏Feb 2025

Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies.

AI & Machine LearningHealthtechMedical Devices

Co-investorsAdara VenturesAmadeus Capital PartnersAPEX VenturesLifeX VenturesCambridge Innovation CapitalColumbus Venture Partners+1 more

Sidekick Healthsidekickhealth.comin𝕏Series A · Oct 2020 · $20M

Sidekick develops digital therapeutics (DTx) programs for people with chronic conditions such as oncology, cardiovascular, metabolic, and inflammatory diseases, using gamification, behavioral psychology, and behavioral economics to improve health outcomes.

AI & Machine LearningDigital HealthHealthtechWellness & Fitness

Co-investorsFrumtak Ventures

XRHealthinJan 2024 · $6M

XR therapeutics platform company that merged with Amelia Virtual Care.

HealthtechNeedham, US

Eran Orr(Founder & Chief Executive Officer)in

Co-investors20/20 HealthCare Partners LLCBridges IsraelFlying Tiger CapitalNOVA Prime

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BinxBinx HealthGradientGradient Denervation TechnologiesOrigo BiopharmaOrivaSidekick

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Asabys Partners made?
Asabys Partners has 34 tracked investments, including 3 dated in the last 24 months.
What stage does Asabys Partners invest at?
Asabys Partners invests at the Seed, Series A, Series B, Series C, Growth stages.
What sectors does Asabys Partners focus on?
Asabys Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
Where is Asabys Partners located?
Asabys Partners is headquartered in Madrid, ES.
Does Asabys Partners lead rounds?
Asabys Partners typically participates in rounds rather than leading them.
Who does Asabys Partners co-invest with?
Asabys Partners most often shares deals with BStartup, AdBio partners, Ship2B, among 20 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Clara Campàs comenta la misión de Asabys Partners

Crónica Global · Clara Campàs

#LifeAfterCovid: Clara Campàs (Asabys Partners), entrevista completa

Capital Cell · Clara Campàs

Co-investors · 1

Ysios Capital

Ysios Capital is a life sciences investor that finances innovative biotech companies worldwide, providing resources to develop novel therapies for indications with high unmet medical needs.

$5.4M – $21.6M

Firms observed investing alongside Asabys Partners, from public investor directories. Shared companies are the overlap with Asabys Partners's recorded portfolio.

Similar investors

Featured in lists